Atlas FDA

Senza Spinal Cord Stimulation (SCS) Systems

FDA premarket approval P130022/S050 · decided 2024-11-01

Approval details

PMA number
P130022
Supplement
S050
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Senza Spinal Cord Stimulation (SCS) Systems
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Applicant
Nevro Corporation
Date received
2023-05-15
Decision date
2024-11-01
Days to decision
536 days
Decision code
APPR
Product code
LGW
Advisory committee
Neurology
Expedited review
No
Location
Redwood City, CA
Statement
Approval for a modification of a warning in the device labeling (i.e., Physician Implant Manual, Patient Manual, Information for Prescribers, and Clinician Programmer Manual) to state that frequencies between 1.2 kHz and 10 kHz may be used to provide paresthesia-free stimulation when the system (i.e., amplitude, pulse width) is configured to deliver paresthesia-free stimulation.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.